Retraction
Ivermectin-functionalized multiwall carbon nanotube enhanced the locomotor activity and neuropathic pain by modulating M1/M2 macrophage and decrease oxidative stress in rat model of spinal cord injury
Paper Information
Record ID:
66143
Author(s):
Journal:
Publication Date:
June 13, 2021
Retraction Date:
February 07, 2025
(<1 year years ago)
Subjects:
Institutions:
- Department of Pharmacology, School of Medicine, AJA University of Medical Sciences, Tehran, Iran
- Department of Pharmacology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
- Department of Pharmacology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran
- Department of Neurosurgery, University Medical Center Tuebingen, Germany
Countries:
Article Type:
Publisher:
Elsevier - Cell Press
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:
Retraction Details
Retraction Reasons:
Nature of Retraction:
Retraction
Retraction Notice:
10.1016/j.heliyon.2025.e42488Citations (12)
12
Total Citations0
Post-Retraction12
Pre-Retraction0
Same DayAdvancements in Antioxidant-Based Therapeutics for Spinal Cord Injury: A Critical Review of Strategies and Combination Approaches
Yang-Jin Shen, Yin-Cheng Huang, Yi‐Chuan Cheng
Antioxidants
Open Access
Published: Dec 2024
3 citations
3 citations
43 days before retraction
Formulation and Ex Vivo Evaluation of Ivermectin Within Different Nano-Drug Delivery Vehicles for Transdermal Drug Delivery
Eunice Maureen Steenekamp, Wilna Liebenberg, Hendrik J. R. Lemmer et al. (4 authors)
Pharmaceutics
Open Access
Published: Nov 2024
81 days before retraction
The involvement and significance of M2 macrophages in neuropathic pain following spinal cord injury: a systematic review
Aidin Shahrezaei, Maryam Sohani, Mohammad Hassan Sohouli et al. (5 authors)
The Journal of Physiological Sciences
Open Access
Published: Sep 2024
1 citation
1 citation
142 days before retraction
Irisin alleviates CFA-induced inflammatory pain by modulating macrophage polarization and spinal glial cell activation
Md. Mahbubur Rahman, Sung-Min Hwang, Eun Jin Go et al. (5 authors)
Biomedicine & Pharmacotherapy
Published: Jul 2024
3 citations
3 citations
200 days before retraction
GDPD3 Deficiency Alleviates Neuropathic Pain and Reprograms Macrophagic Polarization Through PGE2 and PPARγ Pathway
Wenqian Li, Youjia Fan, Haizhen Lan et al. (6 authors)
Neurochemical Research
Open Access
Published: May 2024
1 citation
1 citation
263 days before retraction
Ivermectin ameliorates bleomycin-induced lung fibrosis in male rats by inhibiting the inflammation and oxidative stress
Fatemeh Habibi Razi, Razieh Mohammad Jafari, Mohammad Amin Manavi et al. (8 authors)
Immunopharmacology and Immunotoxicology
Published: Jan 2024
2 citations
2 citations
389 days before retraction
Knowledge Mapping of Macrophage in Spinal Cord Injury: A Bibliometric Analysis
Jinxiang Shang, Chao Jiang, Junhui Cai et al. (10 authors)
World Neurosurgery
Open Access
Published: Sep 2023
4 citations
4 citations
513 days before retraction
Oxidative stress and COVID-19-associated neuronal dysfunction: mechanisms and therapeutic implications
Dylan Bowen, Suhrud Pathak, Rishi Nadar et al. (10 authors)
Acta Biochimica et Biophysica Sinica
Open Access
Published: Apr 2023
7 citations
7 citations
651 days before retraction
Nanocarriers as an Emerging Tool for Drug Delivery to Combat Neurodegenerative Diseases
Pooja Sharma, Damanpreet Singh
Unknown Journal
Published: Jan 2023
768 days before retraction
Ivermectin: A Controversial Focal Point during the COVID-19 Pandemic
Manuel Castillejos‐López, Luz María Torres‐Espíndola, Juan Carlos Huerta-Cruz et al. (15 authors)
Life
Open Access
Published: Sep 2022
7 citations
7 citations
885 days before retraction
Ivermectin: recent approaches in the design of novel veterinary and human medicines
Maiara Callegaro Velho, Diego Fontana de Andrade, Ruy Carlos Ruver Beck
Pharmaceutical Development and Technology
Published: Sep 2022
6 citations
6 citations
886 days before retraction
Central Effects of Ivermectin in Alleviation of Covid-19-induced Dysauto-nomia
Αθανάσιος Αλεξίου, Gaber El‐Saber Batiha, Hayder M. Al‐kuraishy et al. (4 authors)
Current Drug Targets
Published: Aug 2022
10 citations
10 citations
911 days before retraction
Quick Stats
Total Citations:
12
Years Since Retraction:
<1 year
Open Access:
Yes
Last Checked:
Jul 23, 2025